-+ 0.00%
-+ 0.00%
-+ 0.00%

Innate Pharma Hosts Event on IPH4502 Phase 1 Data and Development Outlook

PUBT·11/11/2026 06:00:44
Listen to the news
Innate Pharma Hosts Event on IPH4502 Phase 1 Data and Development Outlook
  • Innate Pharma will host an in-person and virtual IPH4502 event in London on November 18, 2026, at 11 a.m. ET/4 p.m. GMT.
  • Presentations will review Phase 1 dose-escalation results for the Nectin-4 ADC, covering safety, pharmacokinetics and antitumor activity.
  • Yohann Loriot will provide clinical perspective on urothelial cancer; management will discuss the drug's development outlook.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Innate Pharma SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20261110192535) on November 11, 2026, and is solely responsible for the information contained therein.